MOONLAKE IMMUNOTHERAPEUTICS
MLTXNASDAQ🏆 #1933 by market capEarnings Nov 4US Equity
$17.22▲ $0.65 (+3.77%)
Live1h—
24h▲ 3.8%
7d▼ 2.0%
14d▼ 6.3%
30d▼ 15.7%
1y▼ 68.7%
🏦Market Cap
$1.42B
Small Cap
📈Revenue Growth (YoY)
—
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
—
Otter Score
59
Weak
📊
Analyst Ratings
Price
$17.22
Total
19
Raised
2
Lowered
2
Avg PT
$40.00
H / L
$45 / $35
| Institution | Action | Rating | Date |
|---|---|---|---|
HC Wainwright & Co. | Reiterated | Buy | 2026-07-20 |
Leerink Partners | Reiterated | Outperform | 2026-07-01 |
BTIG | Reiterated | Buy | 2026-06-09 |
Needham | Reiterated | Buy | 2026-05-12 |
Wolfe Research | Upgraded | Underperform → Outperform | 2026-03-23 |
Rothschild & Co | Upgraded | Neutral → Buy | 2026-03-19 |
Clear Street | Reiterated | Buy | 2026-03-11 |
RBC Capital | Reiterated | Sector Perform | 2026-03-02 |
Oppenheimer | Reiterated | Outperform | 2026-02-24 |
Goldman Sachs | Downgraded | Neutral → Sell | 2026-01-15 |
Citigroup | Downgraded | Neutral → Sell | 2025-10-29 |
Wedbush | Reiterated | Outperform | 2025-09-30 |
Guggenheim | Reiterated | Buy | 2025-09-30 |
Stifel | Reiterated | Buy | 2023-12-18 |
Cantor Fitzgerald | Reiterated | Overweight | 2023-11-08 |
Barclays | Reiterated | Equal Weight | 2023-09-12 |
Jefferies | Reiterated | Buy | 2022-11-11 |
SVB Leerink | Reiterated | Outperform | 2022-08-25 |
Cowen & Co. | Reiterated | Outperform | 2022-07-07 |
One row per institution, most recent rating